Skip to content
WeighLab

Immortals vs Joey Med

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Immortals

Provider comparison

Patients comfortable paying for three months of treatment upfront who want weight-loss prescribing alongside longevity services.

Semaglutide / month
$196/moEquivalent (personalized-dose compounded plan; $588 quarterly upfront, before optional membership discount)
Tirzepatide / month
$255/moEquivalent (personalized-dose compounded plan; $765 quarterly upfront, before optional membership discount)
Index 55/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Immortals pricing Read review

Joey Med

Provider comparison

Shoppers who want to pick a molecule-agnostic 'Core / Plus Core' tier and pay per 4, 8, or 12 weeks rather than a recurring monthly subscription.

Semaglutide / month
$199/moPromotional rate, compounded
Tirzepatide / month
$275/moPromotional rate, compounded
Index 54/100 · Grade CChecked August 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Joey Med pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Immortals has the higher Cost-Efficiency Index: 55/100 versus 54/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Immortals
Coverage not published
Joey Med
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Immortals

Joey Med

Semaglutide / month
Immortals: $196/moEquivalent (personalized-dose compounded plan; $588 quarterly upfront, before optional membership discount)
Joey Med: $199/moPromotional rate, compounded
Tirzepatide / month
Immortals: $255/moEquivalent (personalized-dose compounded plan; $765 quarterly upfront, before optional membership discount)
Joey Med: $275/moPromotional rate, compounded
Semaglutide / year (modeled)
Immortals: $2,352
Joey Med: $2,388
Tirzepatide / year (modeled)
Immortals: $3,060
Joey Med: $3,300
State availability
Immortals: Coverage not published
Joey Med: All 50 states
Oral / sublingual option listed
Immortals: Yes
Joey Med: Not listed
Brand-name access listed
Immortals: Yes
Joey Med: Not confirmed
Provider facts checked
Immortals: October 2026
Joey Med: August 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Immortals

Patients comfortable paying for three months of treatment upfront who want weight-loss prescribing alongside longevity services.

Reasons to consider it

  • Publishes standard personalized-dose prices separately from membership discounts
  • Offers compounded injections plus brand-name injectable and oral options
  • Physician review and ongoing messaging are included

What to weigh up

  • Compounded plans require three months paid upfront: $588 semaglutide or $765 tirzepatide before discounts
  • Displayed member prices require a separate $365 annual membership
  • The compounding pharmacy and medical director are not named

Compounded drugs are not FDA-approved. Understand the medication options.

Check Immortals pricing Read the full Immortals review

Joey Med

Shoppers who want to pick a molecule-agnostic 'Core / Plus Core' tier and pay per 4, 8, or 12 weeks rather than a recurring monthly subscription.

Reasons to consider it

  • The site's own embedded pricing data is fully itemized by tier (4/8/12 weeks) for all three products
  • Molecule names are disclosed on the category page even though individual product pages use branded tier names
  • Legal entity is disclosed via the site's own structured data: MD Telehealth Platform LLC DBA Joey Med

What to weigh up

  • The current roster's prices were stale: $279 was the crossed-out list price for semaglutide (actual: $199), and $399 belonged to the High Dose tirzepatide tier, not the standard $275 entry tier
  • Drug names are buried under branded tier names on the product pages themselves
  • No LegitScript verification link exists anywhere on the site

Compounded drugs are not FDA-approved. Understand the medication options.

Check Joey Med pricing Read the full Joey Med review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

ImmortalsJoey Med
Normalized Cost/Month
Immortals:
37/100
Joey Med:
43/100
Price Transparency
Immortals:
78/100
Joey Med:
30/100
Nationwide Access
Immortals:
24/100
Joey Med:
86/100
Formulation Options
Immortals:
90/100
Joey Med:
66/100
Clinical Oversight
Immortals:
88/100
Joey Med:
61/100
Contract Flexibility
Immortals:
20/100
Joey Med:
47/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to ImmortalsAlternatives to Joey Med
More provider matchups
CoreAge Rx vs ImmortalsCoreAge Rx vs Joey Med
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.